The CytonPro-5000 receives 501(k) clearance from the US FDA
August 23, 2022The CytonPro-5000 received 501(k) clearance from the US Food and Drug Administration in August 2022. 510(k) clearance from the FDA gives a manufacturer permission to market its product in the United States, and this FDA clearance is a significant milestone for CytonSys. The CytonPro-5000, CytonSys’s flagship laser product for photobiomodulation...
Using Light Therapy to Promote Rejuvenation for Anti-aging
July 19, 2022One can look at the aging process as the degradation of cellular processes. In the skin this results in reduced collagen production, leaving fine lines and wrinkles. In addressing skin aging, consumers take several approaches to attempt to rejuvenate the aging skin, often resorting to creams and skin applications. These...
Light Therapy has a Bright Future in Treating Certain Brain Conditions
June 14, 2022Low-level light therapy (LLLT) based on photobiomodulation (PBM) has been used to treat depression and other mood disorders for many years. In fact, the use of light to treat health conditions is not a new concept. For centuries, various cultures have used sunlight to help relieve pain and promote healing....
The Benefits of Near-Infrared Light Therapy in the Treatment of COVID-19
June 2, 2022According to recent research, COVID-19 can cause neurocognitive decline, even in patients who have mild or asymptomatic infections. The most common symptoms include problems with memory, attention, and executive function. In addition, patients may also experience changes in mood and behavior, such as anxiety, depression, and irritability. While the exact...
Reversing the Effects of Severe Covid-19 With Light Therapy
May 19, 2022Severe COVID-19 can lead to long-term cognitive impairment, equivalent to 20 years of aging, according to a study by Cambridge University. The research, published in the journal eClinicalMedicine, found that people who had severe COVID-19 were more likely to experience brain fog, problems with attention and executive function, and difficulty...
